Immunotherapy Alone or in Combination with Stereotactic Body Radiotherapy in Advanced Lung Cancer: A Pooled Analysis of Randomized Clinical Trials

BACKGROUND: Immunotherapy has revolutionized the treatment of advanced lung cancer. Nevertheless, it remains unclear whether adding stereotactic body radiotherapy (SBRT) to immunotherapy (IT) further improves responses and survival outcomes. Therefore, in this pooled analysis, we comprehensively com...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bi-Cheng, Kuang, Bo-Hua, Lin, Guo-He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553518/
https://www.ncbi.nlm.nih.gov/pubmed/36245995
http://dx.doi.org/10.1155/2022/7506300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553518/
https://www.ncbi.nlm.nih.gov/pubmed/36245995
http://dx.doi.org/10.1155/2022/7506300

Ejemplares similares